Pulmonary Arterial Hypertension

Endothelin Receptor Antagonists (ERAs) to Hold Over 45% Revenue Share in Global Pulmonary Arterial Hypertension (PAH) Market: Fact.MR

Fact.MR, a market research and competitive intelligence provider, has conducted a comprehensive analysis on the pulmonary arterial hypertension (PAH) market, which is expected to rise at a CAGR of 5.4% …

Endothelin Receptor Antagonists (ERAs) to Hold Over 45% Revenue Share in Global Pulmonary Arterial Hypertension (PAH) Market: Fact.MR Read More
Cardiogenic Shock

Cardiogenic Shock Market to Be Dominated By Mechanical Circulatory Support (MCS) Devices With Over 80% Share: Fact.MR Study

According to Fact.MR, a market research and competitive intelligence provider, the cardiogenic shock market is set to see strong expansion, expecting an incline of 6.2% CAGR across the 2022-2032 assessment …

Cardiogenic Shock Market to Be Dominated By Mechanical Circulatory Support (MCS) Devices With Over 80% Share: Fact.MR Study Read More